Re-evaluating Safety and Effectiveness of Dabigatran Versus Warfarin in a Nationwide Data Environment: A Prevalent New-User Design Study

INTRODUCTION: The new user cohort design is widely used to assess the effects of a new drug, such as dabigatran, but inherently excludes some users due to prior use of the comparator drug, for example warfarin. The prevalent new-user design offers a solution that includes all eligible users of the n...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Hui-Min Diana, Lai, Chao-Lun, Dong, Yaa-Hui, Tu, Yu-Kang, Chan, K. Arnold, Suissa, Samy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702531/
https://www.ncbi.nlm.nih.gov/pubmed/31240630
http://dx.doi.org/10.1007/s40801-019-0156-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702531/
https://www.ncbi.nlm.nih.gov/pubmed/31240630
http://dx.doi.org/10.1007/s40801-019-0156-2

Ejemplares similares